
Owkin
TechBio
Series B – $230M raised
Created in 2016
201-500 employees including 11-20 in the USA
Understanding complex biology through AI
Owkin is an AI company on a mission to solve the complexity of biology. It is building the first Biological Artificial Super Intelligence (BASI) by combining powerful biological large language models, multimodal patient data, and agentic software. At the heart of this system is Owkin K, an AI copilot and its new LLM fine-tuned on biology called Owkin Zero, used by researchers, clinicians, and drug developers to better understand biology, validate scientific hypotheses, and deliver better diagnostics and therapies faster.
CONTACT INFORMATION
Dinesh Divakaran
VP, Business Development
New York, NY, USA
dinesh.divakaran@owkin.com

DISCOVER MORE

